HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mercedes Robledo Selected Research

Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))

1/2019Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mercedes Robledo Research Topics

Disease

84Neoplasms (Cancer)
05/2024 - 08/2004
40Paraganglioma (Paragangliomas)
04/2024 - 08/2002
28Pheochromocytoma
04/2024 - 08/2013
16Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 04/2005
10Neoplasm Metastasis (Metastasis)
12/2023 - 10/2014
9Hypoxia (Hypoxemia)
12/2023 - 12/2010
6Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 11/2011
5Peripheral Nervous System Diseases (PNS Diseases)
01/2019 - 08/2012
3Pituitary Neoplasms (Pituitary Adenoma)
05/2024 - 03/2007
3Disease Progression
11/2023 - 01/2020
3Carcinogenesis
01/2023 - 06/2015
3Kidney Neoplasms (Kidney Cancer)
01/2023 - 05/2019
3Melanoma (Melanoma, Malignant)
05/2019 - 01/2016
3Multiple Endocrine Neoplasia Type 2a (MEN 2)
12/2017 - 01/2006
2Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2024 - 11/2006
2Sarcoma (Soft Tissue Sarcoma)
12/2023 - 01/2023
2Ovarian Neoplasms (Ovarian Cancer)
01/2019 - 02/2011
2Adenoma (Adenomas)
01/2017 - 06/2007
2Hyperplasia
01/2017 - 04/2005
2Genetic Predisposition to Disease (Genetic Predisposition)
11/2015 - 01/2015
2Carcinoma (Carcinomatosis)
02/2011 - 06/2007
2T-Cell Lymphoma (Lymphoma, T Cell)
11/2007 - 08/2004
2Lymphoma (Lymphomas)
11/2007 - 08/2004
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2007 - 08/2004
1Acromegaly
05/2024
1Pain (Aches)
04/2024
1Hypertension (High Blood Pressure)
04/2024
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2020
1Dwarfism
11/2020

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
01/2023 - 08/2002
17Succinate Dehydrogenase (Fumarate Reductase)IBA
12/2023 - 04/2005
14Biomarkers (Surrogate Marker)IBA
05/2024 - 09/2008
12CatecholaminesIBA
04/2024 - 11/2014
12DNA (Deoxyribonucleic Acid)IBA
11/2020 - 08/2004
11Messenger RNA (mRNA)IBA
01/2020 - 11/2007
8MicroRNAs (MicroRNA)IBA
01/2022 - 02/2011
7Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 02/2011
6Tyrosine Kinase InhibitorsIBA
11/2023 - 11/2011
6EnzymesIBA
05/2022 - 11/2007
5Phosphotransferases (Kinase)IBA
04/2023 - 08/2013
53-methoxytyramine (methoxytyramine)IBA
01/2023 - 04/2017
5NormetanephrineIBA
01/2023 - 05/2012
5MetanephrineIBA
01/2023 - 05/2012
4Succinic Acid (Succinate)IBA
12/2023 - 10/2014
4MTOR InhibitorsIBA
01/2023 - 11/2017
4TubulinIBA
09/2012 - 04/2010
3Epinephrine (Adrenaline)FDA LinkGeneric
12/2023 - 02/2015
3Sunitinib (Sutent)FDA Link
11/2023 - 11/2011
3Adrenergic Agents (Adrenergic Drugs)IBA
01/2022 - 04/2017
3FumaratesIBA
01/2019 - 10/2014
3Myc associated factor XIBA
11/2014 - 06/2011
2Sirolimus (Rapamycin)FDA Link
01/2023 - 05/2018
2Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2020 - 04/2019
2endothelial PAS domain-containing protein 1IBA
01/2020 - 05/2019
2Dopamine (Intropin)FDA LinkGeneric
04/2019 - 06/2016
2Fumarate Hydratase (Fumarase)IBA
01/2019 - 05/2014
2alpha-hydroxyglutarateIBA
01/2019 - 01/2019
2EverolimusFDA Link
01/2018 - 01/2017
2Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2018 - 07/2012
2Complementary DNA (cDNA)IBA
01/2018 - 07/2012
2temsirolimusFDA Link
01/2018 - 11/2017
2Mechanistic Target of Rapamycin Complex 1IBA
11/2017 - 01/2017
2ParaffinIBA
01/2017 - 07/2012
2RacivirIBA
01/2017 - 06/2007
2SuspensionsIBA
01/2017 - 01/2015
2Tumor Biomarkers (Tumor Markers)IBA
03/2016 - 08/2004
2Cyclin-Dependent Kinase Inhibitor p27IBA
03/2012 - 06/2007
2Cytochrome P-450 CYP3AIBA
11/2011 - 11/2007
1Growth Hormone (Somatotropin)IBA
05/2024
1Dopamine Agonists (Dopamine Agonist)IBA
05/2024
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
05/2024
1Pro-Opiomelanocortin (Proopiomelanocortin)IBA
05/2024
1CannabinoidsIBA
04/2024
1CannabidiolIBA
04/2024
1Mitogen-Activated Protein KinasesIBA
12/2023
1Temozolomide (Temodar)FDA LinkGeneric
11/2023
1Radioisotopes (Radionuclides)IBA
11/2023
1Dacarbazine (DIC)FDA LinkGeneric
11/2023
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2023
1Vincristine (Oncovin)FDA LinkGeneric
11/2023
1Imatinib Mesylate (Gleevec)FDA Link
01/2023
1Deubiquitinating EnzymesIBA
01/2023
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2023
1somatostatin receptor 2IBA
01/2023
1ProteomeIBA
01/2023
1regorafenibIBA
01/2023
1Circulating MicroRNAIBA
01/2022
1Thyrotropin AlfaFDA LinkGeneric
01/2022
1Telomerase (Telomerase Reverse Transcriptase)IBA
09/2021
1xanthurenic acidIBA
06/2021
1KynurenineIBA
06/2021
1P-2 (P 2)IBA
06/2021
1Inositol (Myoinositol)IBA
06/2021
1Sialic AcidsIBA
06/2021
1ChromatinIBA
11/2020
1tryptophyltryptophanIBA
11/2020

Therapy/Procedure

13Therapeutics
04/2024 - 11/2007
5Drug Therapy (Chemotherapy)
11/2023 - 11/2006
3Drug Tapering
01/2017 - 11/2011
2Immunotherapy
02/2024 - 01/2023